Reducing the Cost of Cancer Care: How to Bend the Curve Downward
Overview
Affiliations
Health care and cancer care costs are rising unsustainably such that insurance costs have doubled in 10 years. Oncologists find themselves both victims of high costs and the cause of high-cost care by what we do and what we do not do. We previously outlined five ways that oncologists could personally bend the cost curve downward and five societal attitudes that would require change to lower costs. Here, we present some practical ways to reduce costs while maintaining or improving quality, including: 1) evidence-based surveillance after curative therapy; 2) reduced use of white cell stimulating factors (filgrastim and pegfilgrastim); 3) better integration of palliative care into usual oncology care; and 4) use of evidence-based, cost-conscious clinical pathways that allow appropriate care and lead to equal or better outcomes at one-third lower cost.
Marginal health care expenditures for melanoma care in the United States.
Olateju O, Li J, Thornton J, Aparasu R J Manag Care Spec Pharm. 2024; 30(12):1364-1374.
PMID: 39612258 PMC: 11607212. DOI: 10.18553/jmcp.2024.30.12.1364.
Kumar A, Owen J, Sloat N, Maynard E, Hill V, Hubbard C Curr Oncol. 2024; 31(11):7244-7257.
PMID: 39590164 PMC: 11593073. DOI: 10.3390/curroncol31110534.
Danis M, Abernethy A, Zafar S, Samsa G, Wolf S, Howie L BMC Health Serv Res. 2014; 14:315.
PMID: 25038783 PMC: 4112612. DOI: 10.1186/1472-6963-14-315.